Rmb Capital Management, LLC Biogen Inc. Transaction History

Rmb Capital Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 15, 2019	SELL	$216.71 - $338.96 $156,681 - $245,068	-723 Closed	0 $0
Q4 2018 Feb 13, 2019	SELL	$278.5 - $352.75 $1.92 Million - $2.44 Million	-6,911 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$293.51 - $383.83 $1.5 Million - $1.97 Million	5,126 Added 287.17%	6,911 $2.44 Million
Q2 2018 Aug 13, 2018	SELL	$257.52 - $306.91 $65,925 - $78,568	-256 Reduced 12.54%	1,785 $0
Q4 2017 Feb 14, 2018	BUY	$307.64 - $344.58 $10,152 - $11,371	33 Added 1.64%	2,041 $650,000
Q3 2017 Nov 14, 2017	BUY	$281.15 - $329.69 $1,686 - $1,978	6 Added 0.3%	2,008 $629,000
Q2 2017 Aug 14, 2017	BUY	N/A	2,002	2,002 $543,000

1,050

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $28B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Rmb Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Rmb Capital Management, LLC with notifications on news.